Wikidata

(Q63229507)

English

89Zr-labeled Pembrolizumab in Patients With Non-small-cell Lung Cancer

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
89Zirconium-labeled Pembrolizumab as Predictive Imaging Biomarker of Response and Toxicity in Pembrolizumab Treated Patients With Non-small-cell Lung Cancer - a Feasibility Study (English)
0 references
country
Netherlands
0 references
start time
20 January 2017
0 references
end time
1 December 2019
0 references
number of participants
10
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63229507&oldid=2149411785"